Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes

Human Molecular Genetics

Volumn 10, Issue 26, 2001, Pages 3009-3016

  Gutmann, David H ^a   Wu, Yan Li ^a   Hedrick, Nicolé M ^a   Zhu, Yuan ^b   Guha, Abhijit ^c   Parada, Luis F ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CADHERIN; NEUROMODULIN; RAS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER GRADING; CANCER SUSCEPTIBILITY; CELL ADHESION; CELL FUNCTION; CELL GROWTH; CELL MOTILITY; CELL SPREADING; CONTROLLED STUDY; CYTOSKELETON; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; HETEROZYGOSITY; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0035894746     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.26.3009     Document Type: Article

References (50)

1. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 optic pathway glioma task force
2. Precocious puberty in children with neurofibromatosis type 1
3. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas
4. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations
5. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
6. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients
7. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes
8. Identification and characterization of the neurofibromatosis type 1 gene product
9. Identification of the neurofibromatosis type 1 gene product
10. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins
11. Somatic mutations in the neurofibromatosis 1 gene in human tumors
12. The catalytic domain of the neurofibromatosis type 1 gene product stimulates RAS GTPase and complements ira mutants of S.cerevisiae
13. The neurofibromatosis type 1 gene encodes a protein related to GAP
14. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/akt signaling in a neurofibromatosis 1 astrocytoma
15. Cognitive function and academic performance in children with neurofibromatosis type 1
16. Specific learning disability in children with neurofibromatosis type 1: Significance of MRI abnormalities
17. Neurofibromatosis type 1: Pathologic substrate of high signal intensity foci in the brain
18. Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains
19. The neurofibromatosis type 1 (NF1) gene: Beyond positional cloning
20. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation
21. Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes
22. Astrocyte-specific expression of activated RAS results in malignant astrocytomas in a transgenic mouse model of human astrocytomas
23. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain
24. The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts
25. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo
26. Schwann cells from neurofibromin-deficient mice exhibit activation of p21-RAS, inhibition of cell proliferation and morphological changes
27. Increasing complexity of Ras signaling
28. Quantitative effects of Nf1 inactivation on in vivo hematopoiesis
29. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia
30. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice
31. Loss of Nf1 results in inactivation of the Ras signaling pathway and leads to aberrant growth in hematopoietic cells
32. Calmodulin binds to K-ras, but not to H- or N-Ras, and modulates its downstream signaling
33. Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1
34. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A
35. The neurofibromatosis type 1 gene product, neurofibromin, associates with microtubules
36. Characterization of full-length neurofibromin: Tubulin inhibits RAS GAP activity
37. Mutations in the GAP-relateddomain impair the ability of neurofibromin to associate with microtubules
38. Co-capping of neurofibromin, but not of GAP, with surface immunoglobulin in B-lymphocytes
39. Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons
40. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region
41. Glycoysl phosphatidylinositol-anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion
42. Inhibition of motor axon growth by T-cadherin substrata
43. Expression of T-cadherin (CDH13, H-cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells
44. Phosphorylation-site mutagenesis of the growth-associated protein GAP-43 modulates its effects on cell spreading and morphology
45. GAP43, MARCKS, and CAP23 modulate PI(4,5)P2 at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism
46. Growth-associated protein 43 is down-regulated in cultured astrocytes
47. Severely decreased MARCKS expression correlates with RAS reversion but not with mitogen responsiveness
48. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues
49. Increased expression of the neurofibromatosis 1 (NF1) tumor suppressor gene protein, neurofibromin, in reactive astrocytes in vitro